Liu Tao, Wang Chaofan, Yin Jie, Wang Lili, Xuan Haochen, Yan Yan, Chen Junhong, Bao Jieli, Li Dongye, Xu Tongda
Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.
Ther Clin Risk Manag. 2022 Aug 15;18:813-823. doi: 10.2147/TCRM.S374866. eCollection 2022.
Coronary microvascular obstruction (CMVO) is closely associated with poor prognosis of ST-segment elevation myocardial infarction (STEMI) patients. However, data showing the comparison between cardiac magnetic resonance feature tracking (CMR-FT) and speckle tracking echocardiography (STE) combined with low-dose dobutamine stress echocardiography (LDDSE) in evaluating CMVO was scarcely available. We aimed to explore and compare the predictive value between CMR-FT and STE+LDDSE in detecting CMVO.
Sixty-one STEMI patients were executed cardiac magnetic resonance and echocardiography within the first 5-7 days after primary percutaneous coronary intervention (PCI). The myocardial strain analysis was performed in STE, STE+LDDSE, and CMR-FT, and strain parameters included radial strain (RS), circumferential strain (CS), and longitudinal strain (LS). ROC curves were performed to predict infarcted myocardium segments with CMVO.
Finally, 324 infarcted myocardium segments were analyzed, including 100 infarcted segments with CMVO and 224 segments without CMVO by the gold standard assessment of late gadolinium-enhancement cardiac magnetic resonance imaging (LGE-CMR). The results showed that CS was generally superior to RS and LS in identifying CMVO. CS in CMR-FT facilitated the detection of CMVO, with a sensitivity, specificity, and accuracy of 78.00%, 81.25%, and 80.25%, respectively. The sensitivity, specificity, and accuracy of CS in STE combined with LDDSE were better than STE alone (76.00% vs 60.00%, 79.91% vs 64.29%, and 78.70% vs 62.96%, < 0.05). In addition, CMR-FT is not superior to STE+LDDSE for detection of CMVO ( > 0.05).
Low-dose dobutamine can improve the clinical value of STE for evaluating CMVO in STEMI patients. Compared with CMR-FT, STE+LDDSE might be a better choice for STEMI patients because of its safety, convenience, and low-cost.
冠状动脉微血管阻塞(CMVO)与ST段抬高型心肌梗死(STEMI)患者的不良预后密切相关。然而,关于心脏磁共振特征追踪(CMR-FT)与斑点追踪超声心动图(STE)联合低剂量多巴酚丁胺负荷超声心动图(LDDSE)在评估CMVO方面的比较数据却很少。我们旨在探讨并比较CMR-FT和STE+LDDSE在检测CMVO方面的预测价值。
61例STEMI患者在初次经皮冠状动脉介入治疗(PCI)后的第5-7天内接受了心脏磁共振和超声心动图检查。在STE、STE+LDDSE和CMR-FT中进行心肌应变分析,应变参数包括径向应变(RS)、圆周应变(CS)和纵向应变(LS)。绘制ROC曲线以预测存在CMVO的梗死心肌节段。
最终,通过钆增强延迟心脏磁共振成像(LGE-CMR)的金标准评估,分析了324个梗死心肌节段,其中包括100个存在CMVO的梗死节段和224个不存在CMVO的节段。结果显示,在识别CMVO方面,CS总体上优于RS和LS。CMR-FT中的CS有助于CMVO的检测,其灵敏度、特异度和准确度分别为78.00%、81.25%和80.25%。STE联合LDDSE中CS的灵敏度、特异度和准确度均优于单独的STE(分别为76.00%对60.00%、79.91%对64.29%、78.70%对62.